Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grosset

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 25, 1999
A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in FranceJ Robert, F Boulahbal, D Trystram, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1994
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendationsB P Vareldzis, J Grosset, I de Kantor, et al.
The American Review of Respiratory Disease|December 1, 1993
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in miceB Ji, C Truffot-Pernot, C Lacroix, et al.
Acta Leprologica|October 1, 1986
[Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences]J Millan, G Roux, S Loko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le SidaT May, F Brel, C Beuscart, et al.
Presse Medicale (Paris, France : 1983)|December 20, 1986
[In vitro effect of piperacillin on aerobic bacteria. Variations according to the phenotypes of resistance to beta-lactam antibiotics]V Jarlier, C J Soussy, M Chanal, et al.
Infection|January 1, 1997
A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infectionsB Dautzenberg, C Truffot-Pernot, J Hazebroucq, et al.
American Journal of Respiratory and Critical Care Medicine|May 12, 2000
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimensN Daniel, N Lounis, B Ji, et al.
The American Review of Respiratory Disease|October 1, 1992
Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspectsJ J Rouby, E Martin De Lassale, P Poete, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Experimental results on chloroquine and AIDS-related opportunistic infectionsJ R Boelaert, R Appelberg, M S Gomes, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 25, 1999
A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in FranceJ Robert, F Boulahbal, D Trystram, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1994
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendationsB P Vareldzis, J Grosset, I de Kantor, et al.
The American Review of Respiratory Disease|December 1, 1993
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in miceB Ji, C Truffot-Pernot, C Lacroix, et al.
Acta Leprologica|October 1, 1986
[Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences]J Millan, G Roux, S Loko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le SidaT May, F Brel, C Beuscart, et al.
Presse Medicale (Paris, France : 1983)|December 20, 1986
[In vitro effect of piperacillin on aerobic bacteria. Variations according to the phenotypes of resistance to beta-lactam antibiotics]V Jarlier, C J Soussy, M Chanal, et al.
Infection|January 1, 1997
A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infectionsB Dautzenberg, C Truffot-Pernot, J Hazebroucq, et al.
American Journal of Respiratory and Critical Care Medicine|May 12, 2000
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimensN Daniel, N Lounis, B Ji, et al.
The American Review of Respiratory Disease|October 1, 1992
Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspectsJ J Rouby, E Martin De Lassale, P Poete, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Experimental results on chloroquine and AIDS-related opportunistic infectionsJ R Boelaert, R Appelberg, M S Gomes, et al.
Pageof 18